The CARDS project aims to develop and expand tools, services, and training offered to researchers of the Berlin University Alliance (BUA) on the topic of research data management (RDM).

The project "Berlin University Alliance Open Science Magnifiers" continues and further develops the systematic monitoring of Open Science practices. This includes visualizations of indicators for open practices, as well as highlighting of specific best-practice examples.

Our DFG-Emmy Noether Program-funded lab has two main focuses: First, we are developing in vivo tissue regeneration as a therapeutic strategy. Second, we aim to understand the dynamics between hematopoietic and hepatic systems in development and disease using blood-liver organoids.

Our lab is made up of bioinformaticians, computer scientists, ontologists, curators, and software engineers. Our mission is to develop software resources and algorithms to improve human health. Our research focuses on the development of ontologies and software for translational genomics.

In INFORM-Stroke, we want to compare the results of a multicentre preclinical stroke study with those of systematic reviews. In addition, more in-depth analyses will examine the effect of animal attrition and of meta-analysis decisions on the effect estimates.

Developing services and infrastructure to support companies in implementing ethical requirements for trustworthy AI products for healthcare.

Navigating towards open and responsible research practice in experimental medicine with the Charité quality compass

Understanding the factors that contribute to poor reproducibility in scientific research, and assessment of the effectiveness of interventions aimed at improving reproducibility.

Our aim is to use scientific discoveries to improve human health. To that end we are developing new methods to better prevent diseases and to more precisely and effectively treat them. This booklet lists, in alphabetical order, what we need to achieve these goals. From A to Z, it provides a good first overview of the BIH.

Leveraging funders' unique position in the research ecosystem to drive improvements in clinical trial transparency in Germany, and beyond.